The Global Lyophilized Injectable Drugs Market Size accounted for USD 2.9 Billion in 2021 and is projected to occupy a market size of USD 5.1 Billion by 2030 growing at a CAGR of 6.5% from 2022 to 2030.

Lyophilization is a water removal process used to preserve perishable items. This process is used in manufacturing or parenteral, where the solution has little or no stability. This procedure is completed in four steps. They are freezing, secondary dying, primary dying, and packaging in the conainer. The lyophilized injectable drugs market is expected to grow at a rapid pace owing to the increase in development of pipeline of lyophilized injectable drugs.

Lyophilized Injectable Drugs Market Report Statistics

• Global lyophilized injectable drugs market revenue is projected to reach USD 5.1 Billion by 2030 with a CAGR of 6.5% from 2022 to 2030
• North America lyophilized injectable drugs market share generated over 47% shares in 2021
• Asia-Pacific lyophilized injectable drugs market growth will register impressive CAGR of over 7% from 2022 to 2030
• Based on packaging type, single-use vials recorded over 60% of the overall market share in 2021
• Among type of delivery, prefilled diluent syringes generated shares of over 53% in 2021
• Growth in contract manufacturing services is a popular lyophilized injectable drugs market trend that fuels the industry demand

Global Lyophilized Injectable Drugs Market Dynamics

Market Drivers

• Increasing awareness for healthy life
• Rise in medical conditions such as metabolic and cardiac disorders
• Surge in respiratory disorders
• Extension of pipeline of lyophilized injectable drugs

Market Restraints

• Growing number of product recalls
• Presence of glass particles in the product

Market Opportunities

• Expanding healthcare infrastructure
• Growing number of contract manufacturing and research services

Lyophilized Injectable Drugs Market Report Coverage

Market	Lyophilized Injectable Drugs Market
Lyophilized Injectable Drugs Market Size 2021	USD 2.9 Billion
Lyophilized Injectable Drugs Market Forecast 2030	USD 5.1 Billion
Lyophilized Injectable Drugs Market CAGR During 2022 - 2030	6.5%
Lyophilized Injectable Drugs Market Analysis Period	2018 - 2030
Lyophilized Injectable Drugs Market Base Year	2021
Lyophilized Injectable Drugs Market Forecast Data	2022 - 2030
Segments Covered	By Packaging Type, By Type of Delivery, By Indication, By End-User, And By Geography
Regional Scope	North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
Key Companies Profiled	Schott AG, CIRON Drugs & Pharmaceuticals Pvt. Ltd, Mylan N.V., Baxter, Vetter Pharma, Dickinson and Company, Novartis AG, SHL Group, B. Braun Melsungen AG, and Jubilant HollisterStier.
Report Coverage	Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis

Lyophilized Injectable Drugs Market Growth Factors

Growing health awareness and rise in demand for lyophilized injectable drugs in various medical conditions such as metabolic and cardiac diseases are the major driving factors that are boosting the growth of the lyophilized injectable drugs market. Also, governments stringent regulation and low emission policies across the globe encourage the usage of lyophilized injectable drugs that integrates low rolling resistant tires and aerodynamics that helps in fuel savings as well as reduce carbon emissions which are the key factors driving the growth of the global lyophilized injectable drugs market.

Lyophilized Injectable Drugs Market Insights

The lyophilized injectable drugs are costly in terms of manufacturing process; therefore, the key manufacturers in the global market are investing on R&D activities to offer a substitute method that will help to extend the product’s shelf life. Though, this substitute method requires development related to absorbent stability and biological activity of the material. For instance, for instance, in September 2015, Purdue University has introduced lyophilization association named LyoHUB with an objective to develop advanced freeze-drying technology to make it safer and more affordable for pharmaceuticals and biotech products.

Lyophilized Injectable Drugs Market Segmentation

The global lyophilized injectable drugs market is segmented based on packaging type, type of delivery, indication, end-user, and geography.

Lyophilized Injectable Drugs Market By Packaging Type

• Specialty Packaging
• Point-Of-Care Reconstitution
• Single-Use Vials
• Others

Based on packaging type, the global lyophilized injectable drugs market ismajorly segmented into three sub-segments, which arespecialty packaging, point-of-care reconstitution, single-use vials. The specialty packaging segment is predicted to lead the global lyophilized injectable drugs market owing to the wide spread of lyophilized injectable drugs in several chronic diseases.

Lyophilized Injectable Drugs Market By Type of Delivery

• Single-Step Devices
• Multi-Step Devices
• Prefilled Diluent Syringes
• Proprietary Reconstitution Devices

According to the lyophilized injectable drugs industry analysis, prefilled diluent syringes accounted for the largest market share in 2021 and is expected to continue its trend during the forecast timeframe. A prefilled syringe is a single-dose vaccine container with a needle made by the manufacturer. These syringes are used to collect injectable medications and diluents.

Lyophilized Injectable Drugs Market By Indication

• Infectious Diseases
• Autoimmune Diseases
• Metabolic Conditions
• Others

According to the lyophilized injectable drugs market forecast, metabolic diseases are expected to hold a significant market share between 2022 and 2030. The factors that can be attributed to the increasing demand for lyophilized drugs in a variety of medical conditions, such as metabolic and cardiac diseases, are fueling demand for this segment. On the other hand, infectious diseases sub-segment is anticipated to witness significant growth rate in the coming years.

Lyophilized Injectable Drugs Market By End-User

• Hospitals
• Ambulatory Surgery Centers (ASCs)
• Specialty Clinics
• Others

Based on end-user segment, hospitals sub-segment gathered considerable amount of share in 2021. The presence of advanced medical equipment, presence of healthcare professionals, and increasing investment in healthcare infrastructure are some of the factors that are driving the hospitals segment. However, specialty clinics sub-segment is likely to attain substantial growth rate from 2022 to 2030. The factors that can be credited to the ease of reconstitution, particularly for vaccines and injectables that need to be administered quickly increase the demand for this segment.

Lyophilized Injectable Drugs Market Regional Outlook

North America

• U.S.
• Canada

Europe

• U.K.
• Germany
• France
• Spain
• Rest of Europe

Asia-Pacific

• India
• Japan
• China
• Australia
• South Korea
• Rest of Asia-Pacific

Latin America

• Brazil
• Mexico
• Rest of Latin America

The Middle East & Africa

• South Africa
• GCC Countries
• Rest of the Middle East & Africa (ME&A)

Lyophilized Injectable Drugs Market Regional Analysis

The North America region is predicted to dominate the lyophilized injectable drugs market owing to technological advancement and huge investment by manufacturers in research and development in this region. Also, due to the huge presence of contract manufacturing and services is expected to drive the lyophilized injectable drugs market in North America region.

Asia-Pacific is projected to grow at high CAGR and expected to create growth opportunities for manufacturers as there is increase in healthcare spending in developing countries. Countries such as Singapore, Malaysia and Thailand are expected to create significant opportunities in the healthcare industry. Moreover, the improved medical infrastructure facilities are likely to boost the demand of the lyophilized injectable drugs market.

Lyophilized Injectable Drugs Market Players

Some of the key vendors operating in the lyophilized injectable drugs market are Schott AG, CIRON Drugs & Pharmaceuticals Pvt. Ltd, Mylan N.V., Baxter, Vetter Pharma, Dickinson and Company, SHL Group, B. Braun Melsungen AG, Jubilant HollisterStier, and others.

Key vendors are highly focused on investment in research and development activities to manufacture innovative lyophilized injectable drugs using advanced technologies. Furthermore, the manufacturers operating in the global lyophilized injectable drugs market are strategically focused product innovation and partnership, merger and acquisition of other players in healthcare industry in order to increase their product portfolio as well as expand their customer base globally.

TABLE OF CONTENT